December 7-9, 2021, Digital Event

The  2nd Annual TIGIT Therapies Summit remains the only dedicated forum gathering biopharma drug developers to discuss this next-generation checkpoint inhibitor to advance clinical progress and deliver to those patients most in need.

This event will allow you to address the key challenges associated with TIGIT therapy development and propel TIGIT to clinical use.